CDC Study Validates Fast-track Diagnostics' Respiratory Assay Panel, Flexible MDx Approach
July 19, 2012
CDC Study Validates Fast-track Diagnostics' Respiratory Assay Panel, Flexible MDx Approach
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Alere Garners Up to $42.2M in Grants and Loans from Gates Foundation for POC MDx Platforms
March 1, 2013 / GenomeWeb Daily News - Quidel Wins Gates Foundation Grant Worth up to $8.3M for Low-Cost Test to Monitor HIV Treatment
February 14, 2013 / PCR Insider - Dx Focus: PEPFAR Funding Drives Cepheid TB Test Uptake; Curetis Starts US Trials for MDx System
December 6, 2012 / PCR Insider - CDC Urges Molecular Testing as Follow Up for Positive HCV Antibody Test Result
August 21, 2012 / GenomeWeb Daily News - Cepheid Inks First in Series of Agreements to Buy Down Price of Xpert TB Test
August 9, 2012 / PCR Insider